Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 13/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7459339 | 0.89 | RAPGEF4 (0.38) | RAPGEF4 | |
| SCHEMBL7457901 | 0.89 | RAPGEF4 (0.44) | RAPGEF4FFAR4 | |
| SCHEMBL12551743 | 0.87 | RAPGEF4 (0.34) | RAPGEF4ALDH1A1 | |
| SCHEMBL85680 | 0.86 | RAPGEF4 (0.42) | RAPGEF4FFAR4CYP1A2CYP2A6 | |
| SCHEMBL5553806 | 0.85 | RAPGEF4 (0.38) | RAPGEF4FFAR4CYP1A2CYP2A6 | |
| SCHEMBL1157695 | 0.85 | RAPGEF4 (0.50) | RAPGEF4ALDH1A1KDM4EMAPTLMNA | |
| SCHEMBL7461430 | 0.85 | RAPGEF4 (0.33) | RAPGEF4 | |
| SCHEMBL7461325 | 0.84 | RAPGEF4 (0.38) | RAPGEF4 | |
| SCHEMBL12551740 | 0.83 | ALDH1A1 (0.36) | RAPGEF4FFAR4ALDH1A1KDM4ELMNA | |
| SCHEMBL9623685 | 0.82 | RAPGEF4 (0.48) | RAPGEF4FFAR4ALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178214-B2 | Material for organic electroluminescence element, organic electroluminescence element, display device and illumination device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178214-B2 | Material for organic electroluminescence element, organic electroluminescence element, display device and illumination device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-7279603-B2 | Boron and aluminum compounds in electronic components | MERCK PATENT GMBH (DE) | 2007-10-09 | — | — | US | disclosed |
| US-20070184301-A1 | Material for organic electroluminescence element, organic electroluminescence element, display device and illumination device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070184301-A1 | Material for organic electroluminescence element, organic electroluminescence element, display device and illumination device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20060241321-A1 | Use of boron and aluminium compounds in electronic components | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-10-26 | — | — | US | disclosed |
| US-7060369-B2 | Use of boron and aluminum compounds in electronic components | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-06-13 | — | — | US | disclosed |
| US-20040058194-A1 | Use of boron and aluminium compounds in electronic components | MERCK PATENT GMBH (DE) | 2004-03-25 | — | — | US | disclosed |
| EP-1217668-A1 | Use of boron and aluminium compounds in electronic devices | Covion Organic Semiconductors GmbH (DE) | 2002-06-26 | — | — | EP | disclosed |
| EP-0775706-B1 | Borates photoinitiators from polyboranes | CIBA SC HOLDING AG (CH) | 2002-06-05 | — | — | EP | disclosed |
| EP-1203999-A2 | Photoinitiator comprising a borane and an electron donating compound | Ciba SC Holding AG (CH) | 2002-05-08 | — | — | EP | disclosed |
| US-6057078-A | PHOTOGRAPHY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| US-5807905-A | POLYMERIZATION OF UNSATURATED COMPOUNDS | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0775706-A2 | Borates photoinitiators from polyboranes | Ciba SC Holding AG (CH) | 1997-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241321-A1 | Use of boron and aluminium compounds in electronic components | SLCO4C1, SLC43A3, OSBP2 | RAPGEF4 659/4885FFAR4 3398/4885ALDH1A1 4488/4885 |
| US-20040058194-A1 | Use of boron and aluminium compounds in electronic components | SLCO4C1, SLC43A3, OSBP2 | RAPGEF4 659/4885FFAR4 3398/4885ALDH1A1 4488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.